Heart failure is a life‐threatening disease and addressing it should be considered a global
health priority. At present, approximately 26 million people worldwide are living with heart …

Heart failure is a global pandemic affecting an estimated 26 million people worldwide and
resulting in more than 1 million hospitalizations annually in both the United States and …

Aims The ESC‐HF Pilot survey was aimed to describe clinical epidemiology and 1‐year
outcomes of outpatients and inpatients with heart failure (HF). The pilot phase was also …

Context It is not known whether recent declines in ischemic heart disease and its risk factors
have been accompanied by declines in heart failure (HF) hospitalization and mortality …

Acute heart failure (AHF) is a common and serious condition that contributes to about 5% of
all emergency hospital admissions in Europe and the USA. Here, we present the …

ESC Guidelines 2389 disclosure forms are kept on file at the European Heart House,
headquarters of the ESC. Any changes in conflict of interest that arise during the writing …

Aims To evaluate how recommendations of European guidelines regarding
pharmacological and non‐pharmacological treatments for heart failure (HF) are adopted in …

Aims The objective of the EuroHeart Failure Survey II (EHFS II) was to assess patient
characteristics, aetiology, treatment, and outcome of acute heart failure (AHF) in Europe in …

Aims The primary objective of the new ESC‐HF Pilot Survey was to describe the clinical
epidemiology of outpatients and inpatients with heart failure (HF) and the …

Background—We examined whether population-level hospitalization rates for heart failure
(HF) and subsequent survival have continued to improve since the turn of the century. We …